BLEOMYCIN (BLENOXANE)

Course overview

Bleomycin is U.S. FDA-approved to treat Hodgkin/non-Hodgkin lymphoma; squamous cell carcinoma of the head/neck, nasopharynx, cervix, vulva, and penis; testicular cancer; and malignant pleural effusion. This continuing education module is designed to give the reader/learner an increased understanding of bleomycin. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.